Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) و Lithium Controlled-Release and Extended-Release Tablets
تحديد تفاعل Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) و Lithium Controlled-Release and Extended-Release Tablets وإمكانية تناولهما معًا.
لم يتم العثور على أي تفاعل بين الأدوية المحددة أو آثار تناولها معاً غير مدروسة جيدًا حتى الآن. يتطلب الأمر المزيد من الوقت لجمع الإحصاءات اللازمة بشأن تفاعلها. يجب مراجعة الطبيب بشأن المزج بين الأدوية.
اسم جنيس: antihemophilic factor
علامة تجارية: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
مرادفات: Antihemophilic factor (human), Antihemophilic Factor (Human)
اسم جنيس: lithium
علامة تجارية: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
مرادفات: Lithium
أثناء التدقيق من توافق وتفاعل الأدوية تمت الاستعانة بيانات المراجع الآتية: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)-Lithium ER
- Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)-Lithium Oral Solution
- Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)-Lithium Salts
- Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)-Lithium Syrup and Oral Solution
- Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)-Lithobid
- Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Antihemophilic Factor (Recombinant) (Nuwiq)
- Lithium Controlled-Release and Extended-Release Tablets-Antihemophilic Factor (Recombinant) (Recombinate)
- Lithium Controlled-Release and Extended-Release Tablets-Antihemophilic Factor (Recombinant) (Xyntha)
- Lithium Controlled-Release and Extended-Release Tablets-Antihemophilic factor (recombinant) pegylated-aucl Intravenous
- Lithium Controlled-Release and Extended-Release Tablets-Antihemophilic factor (recombinant) porcine sequence Intravenous
- Lithium Controlled-Release and Extended-Release Tablets-Antihemophilic factor human
Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) - Lithium Controlled-Release and Extended-Release Tablets 
Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) - Lithium Controlled-Release and Extended-Release Tablets 
Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) - Lithium Controlled-Release and Extended-Release Tablets 
Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) - Lithium Controlled-Release and Extended-Release Tablets 
Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) - Lithium Controlled-Release and Extended-Release Tablets 
Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) - Lithium Controlled-Release and Extended-Release Tablets 
Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) - Lithium Controlled-Release and Extended-Release Tablets 
Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) - Lithium Controlled-Release and Extended-Release Tablets 
Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) - Lithium Controlled-Release and Extended-Release Tablets 
Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) - Lithium Controlled-Release and Extended-Release Tablets 
Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) - Lithium Controlled-Release and Extended-Release Tablets 
Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) - Lithium Controlled-Release and Extended-Release Tablets